| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 06/28/2007 | CA2630739A1 New compounds |
| 06/28/2007 | CA2629991A1 Quinoline derivatives useful in the treatment of mglur5 receptor-mediated disorders |
| 06/28/2007 | CA2629984A1 New compounds |
| 06/28/2007 | CA2629065A1 2 -phenylethylamino derivatives as calcium and/or sodium channel modulators |
| 06/28/2007 | CA2626764A1 Substituted pyrazinone derivatives as alpha2c-adrenoreceptor antagonists |
| 06/27/2007 | EP1801120A1 Co-crystalline complex of IGF-1 and methods of identifying indirect agonists of IGF-1 using the same |
| 06/27/2007 | EP1801106A2 New spirotricyclic derivatives and their use as phosphodiesterase-7 inhibitors |
| 06/27/2007 | EP1801103A1 Preparation of 2-((2,3- dihydro-benzo(1,4) dioxin-5-YL)-(2-hydroxyethyl)-amino)-ethanol and related intermediates |
| 06/27/2007 | EP1800675A1 Composition comprising polyunsaturated fatty acids, proteins and manganese and/or molybden for improving membrane composition |
| 06/27/2007 | EP1800669A1 Orodispersible pharmaceutical composition for oral, oromucosal or sublingual administration of agomelatine |
| 06/27/2007 | EP1799685A2 Polymorphic and amorphous forms of the phosphate salt of 8-fluoro-2-{4-[(methylamino)methyl]phenyl}-1,3,4,5-tetrahydro-6h-azepino[5,4,3-cd]indol-6-one |
| 06/27/2007 | EP1799682A2 Reversible inhibitors of s-adenosyl-l-homocysteine hydrolase and uses thereof |
| 06/27/2007 | EP1799678A1 Process for preparing ziprasidone |
| 06/27/2007 | EP1799673A1 Pyrazole derivatives as phosphodiesterase 4 inhibitors |
| 06/27/2007 | EP1799672A2 Cgrp receptor antagonists |
| 06/27/2007 | EP1799662A2 Methods of chemical synthesis and purification of diaminophenothiazinium compounds including methylthioninium chloride (mtc) |
| 06/27/2007 | EP1799659A1 Compounds for nonsense suppression, and methods for their use |
| 06/27/2007 | EP1799646A1 Novel pyridinone derivatives and their use as positive allosteric modulators of mglur2-receptors |
| 06/27/2007 | EP1799643A1 Indolone derivatives, processes for preparing them and their uses |
| 06/27/2007 | EP1799640A2 Indole compounds useful as serotonin selective agents |
| 06/27/2007 | EP1799306A2 Compositions and methods for treating cognitive disorders |
| 06/27/2007 | EP1799268A2 Magnetic particles for therapy and diagnosis |
| 06/27/2007 | EP1799264A2 Methods and compositions for treating migraine pain |
| 06/27/2007 | EP1799250A2 Use of igfbp-2 in senescence diseases and for the maintenance of organ functions |
| 06/27/2007 | EP1799248A1 Use of il-17f for the treatment and/or prevention of neurologic diseases |
| 06/27/2007 | EP1799227A2 Therapeutic agents targeting the nc ca-atp channel and methods of use thereof |
| 06/27/2007 | EP1799224A1 Memantine for the treatment of childhood behavioral disorders |
| 06/27/2007 | EP1799220A1 Tetrodotoxin and its derivatives for the treatment of peripheral-nervously derived neuropathic pain |
| 06/27/2007 | EP1799219A1 Tetrodotoxin and its derivatives for the treatment of central-nervously derived neuropathic pain |
| 06/27/2007 | EP1799213A2 Novel curcumin analogues and uses thereof |
| 06/27/2007 | EP1684766B1 USE OF 3-AZA-1-OXA-DIBENZO i e,h /i AZULENES FOR THE MANUFACTURE OF PHARMACEUTICAL FORMULATIONS FOR THE TREATMENT AND PREVENTION OF CENTRAL NERVOUS SYSTEM DISEAS AND DISORDERS |
| 06/27/2007 | EP1531812B1 Fused heteroaryl derivatives for use as p38 kinase inhibitors in the treatment of i.a. rheumatoid arthritis |
| 06/27/2007 | EP1414416A4 Drug delivery system for zero order, zero order-biphasic, ascending or descending drug delivery |
| 06/27/2007 | EP1392259B1 Delivery of erectile dysfunction drugs through an inhalation route |
| 06/27/2007 | EP1378236B1 Agents against stress-induced diseases |
| 06/27/2007 | EP1374898B1 Use of interleukin-12 for treating nerve damage |
| 06/27/2007 | EP1368312B1 Benzo[f]isoindole derivatives with affinity to the ep4 receptor |
| 06/27/2007 | EP1366025B1 Agonists of beta-adrenoreceptors |
| 06/27/2007 | EP1355936B1 Polymer conjugates of neublastin and methods of using same |
| 06/27/2007 | EP1289503B1 O/w emulsion |
| 06/27/2007 | EP1284973B1 Inhibitors of alpha l beta 2 mediated cell adhesion |
| 06/27/2007 | EP1121436B1 Non-desensitizing ampa-receptors |
| 06/27/2007 | EP1115383B1 Treatment of acute disorders by sublingual administration of a pharmaceutical composition |
| 06/27/2007 | CN1989244A Inhibitors of tgf-r signaling for treatment of cns disorders |
| 06/27/2007 | CN1989139A Benzothiazole derivatives |
| 06/27/2007 | CN1989128A New 4-benzylidene-piperidin derivatives |
| 06/27/2007 | CN1989127A Kynurenic acid amide derivatives as NR2B receptor antagonists |
| 06/27/2007 | CN1989126A 新的杂环羧酸酰胺衍生物 The new heterocyclic carboxylic acid amide derivatives |
| 06/27/2007 | CN1989124A Quinazolin-4-yl- piperidine and cinnolin-4-yl- piperidine derivatives as pde10 inhibitors for the treatment of cns disorders |
| 06/27/2007 | CN1989119A 新的苯甲酰脲衍生物 The new benzoyl urea derivatives |
| 06/27/2007 | CN1989117A Substituted benzothiazoles |
| 06/27/2007 | CN1989115A Oxazole derivatives as histamine h3 receptor agents, preparation and therapeutic uses |
| 06/27/2007 | CN1989113A 喹唑啉衍生物 Quinazoline derivatives |
| 06/27/2007 | CN1989103A Indole-2 -carboxamidine derivatives as nmda receptor antagonists |
| 06/27/2007 | CN1988896A Use of compounds active on the sigma receptor for the treatment of mechanical allodynia |
| 06/27/2007 | CN1988895A 1-aminocyclohexane derivatives for the treatment of agitation and other behavioral disorders, especially those associated with alzheimer's disease |
| 06/27/2007 | CN1985991A Recipe and preparing process of drug addiction eliminating medicine |
| 06/27/2007 | CN1985984A Medicine composition for treating neurosis |
| 06/27/2007 | CN1985979A Drug addiction eliminating medicine |
| 06/27/2007 | CN1985972A Method for preventing and treating diseases with serial lingzhigu coix seed granules |
| 06/27/2007 | CN1985966A Chinese medicine composition for treating headache, diziness and other diseases caused by liver and kidney deficiency and liver wind |
| 06/27/2007 | CN1985962A Medicine for treating facial neuritis and its preparing method |
| 06/27/2007 | CN1985942A Yin-nourishing and transquilizing medicine composition bolus and its preparing method |
| 06/27/2007 | CN1985918A Chinese medicine composition for rheumatic arthritis, rheumatoid arthritis and other diseases |
| 06/27/2007 | CN1985901A Chinese medicine composition for promoting blood circulation and dredging collaterals and its preparing method and use |
| 06/27/2007 | CN1985896A Use of decombent corydalis total alkaloid as medicine for preventing and treating vascular dementia |
| 06/27/2007 | CN1985890A Process of preparing schisandra granule |
| 06/27/2007 | CN1985887A Medicine composition for treating cardiac and cerebral vascular diseases |
| 06/27/2007 | CN1985866A Application of Chinese medicine composition in treating cardiac and cerebral vascular diseases |
| 06/27/2007 | CN1985836A Medicine composition for treating cerebral ischemia |
| 06/27/2007 | CN1985811A Preparing process of hypericin injection |
| 06/27/2007 | CN1985810A Slow control released methylphenidate hydrochloride capsule and its preparing method |
| 06/27/2007 | CN1323060C MPTP affinity labels |
| 06/27/2007 | CN1322897C Use of IL-18 inhibitors |
| 06/27/2007 | CN1322870C Quality control method for speedwell flavone capsule |
| 06/27/2007 | CN1322864C Nicergoline drip pill and its preparing method |
| 06/27/2007 | CN1322854C Cold drop pills of mulberry and ginger in use for eliminating draft, clearing away heat |
| 06/26/2007 | US7235658 Imidazol derivatives as Raf kinase inhibitors |
| 06/26/2007 | US7235656 Anxiolytic agents with reduced sedative and ataxic effects |
| 06/26/2007 | US7235635 IRAK-4: compositions and methods of use |
| 06/26/2007 | US7235634 Comprises proteolytic enzymes for use as tools to identify modulators for treatment and prevention of gastrointestinal, cell proliferative and inflammatory diseases |
| 06/26/2007 | US7235628 Analogues of GLP-1 |
| 06/26/2007 | US7235581 For therapy of Alzheimer's disease |
| 06/26/2007 | US7235579 Antiinflammatory agents; antidepressants; respiratory system disorders; cognition activators |
| 06/26/2007 | US7235568 N-dihydrobenzofuran-7-yloxyethyl-substituted, e.g., [2-(2,2-Dimethyl-2,3-dihydrobenzofuran-7-yl-oxy)ethyl]-(5-cyclopenten-1-ylpyridin-3-ylmethyl)amine; benzofuran ring may 2-spirocyclopropyl- or 2-spirocyclobutyl-substituted |
| 06/26/2007 | US7235565 Quinoline and quinolinones 4-substituted with a 3-(hetero)cyclylcarbonyl-1-imidazolinyl or 3-(hetero)cyclylcarbonyl-1-imidazolinonyl group; treating diabetes, glomerulonephritis, endotoxic shock, psoriasis, and arthritis |
| 06/26/2007 | US7235561 Compound and a composition including such a compound |
| 06/26/2007 | US7235557 Benzo-1,5-naphthyridine and benzo-2,5-naphthyridine derivatives are used as poly(ADP-ribose) polymerase inhibitors for treating vascular stroke, cerebral ischemia, heart ischemia/reperfusion injury and gout |
| 06/26/2007 | US7235554 Water soluble; treating diseases in which peripheral benzodiazepine receptors are involved such as spinal amyotrophy, amyotrophic lateral sclerosis, cranial and medullar trauma, multiple sclerosis, and diabetic nephropathy |
| 06/26/2007 | US7235552 Cholenic acid amides and pharmaceutical compositions thereof |
| 06/26/2007 | US7235550 Polycyclic azaindole compounds |
| 06/26/2007 | US7235549 Benzamide, heteroarylamide and reverse amides |
| 06/26/2007 | US7235545 (Calcitonin gene related peptide); azepinone ligands; migranes; 1-[(2-methoxyethyl)-2-oxo-6-phenylazepan-3-yl]-4-(2-oxo-2,3-dihydro-1H-imidazo[4,5-b]pyridin-1-yl)piperidine-1-carboxamide |
| 06/26/2007 | US7235541 Neurokinin antagonists for use as medicaments |
| 06/26/2007 | US7235536 Administering sulfated polysaccharide such as cellulose sulfate, dextran sulfate, dermatan sulfate, chondroitin sulfate, pentosan sulfate, fucoidin, mannan sulfate, dextrin sulfate, curdlan sulfate, chitin sulfate, heparin or heparin sulfate for therapy and prophylaxis of fungal infection |
| 06/26/2007 | US7235372 incubating a cell or tissue sample with a purified antibody or an antigen binding fragment that binds specifically to a portion of human NAIP protein, detecting binding of antibody to such cell or tissue sample |
| 06/26/2007 | US7235363 Detecting modulators of brain membrane protein; obtained membrane protein incubated with ligand and labeled compound, measure level of binding |
| 06/26/2007 | US7235267 Brain cell or nerve cell-protecting agents comprising medicinal ginseng |
| 06/26/2007 | US7235264 Cerebral protection with a gas comprising xenon |
| 06/26/2007 | US7235257 Drugs for relieving hemicrania comprising 1-menthol and essential oils |